WebAug 6, 2024 · From AI system, total return is 2982.34% from 3770 forecasts. For PEAR THERAPEUTICS INC stock forecast for 2024, 6 predictions are offered for each month of 2024 with average PEAR THERAPEUTICS INC stock forecast of $4.37, a high forecast of $4.46, and a low forecast of $4.27. WebPEAR chart Today 1 month 6 months Year to date 1 year 5 years Key stats Market capitalization 41.394M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −0.5424 USD About Pear Therapeutics, Inc ISIN US7047231052 Sector Health Technology Industry Medical Specialties Website peartherapeutics.com CEO Corey M. …
Looking For A Top Momentum Stock? Check Out Pear …
WebMar 22, 2024 · The current price is about -194.12% off the estimated low and -2252.94% off the forecast high, based on this estimate. Investors will be thrilled if PEAR’s share price rises to $5.00, which is the median consensus price. At that level, PEAR’s share price would be -1370.59% below current price. WebMar 13, 2024 · Based on short-term price targets offered by five analysts, the average price target for Pear Therapeutics, Inc. comes to $5.00. The forecasts range from a low of … sunheart boho
Pear Therapeutics, Inc. (PEAR) Stock Price, Quote & News - Stock …
WebApr 11, 2024 · Pear Therapeutics - PEAR News Today $0.23 +0.00 (+2.00%) (As of 04/4/2024 03:33 PM ET) Compare Today's Range $0.22 $0.25 50-Day Range $0.21 $1.23 52-Week Range $0.20 $6.74 Volume 277,014 shs Average Volume 676,720 shs Market Capitalization $32.85 million P/E Ratio N/A Dividend Yield N/A Price Target $6.25 Profile … WebGet the latest Pear Therapeutics Inc (PEAR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … WebApr 11, 2024 · Does Pear Therapeutics's stock price have much upside? According to analysts, Pear Therapeutics's stock has a predicted upside of 162.16% based on their 12-month price targets. What analysts cover Pear Therapeutics? Pear Therapeutics has been rated by BTIG Research, Chardan Capital, and Credit Suisse Group in the past 90 days. sun healthy